These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effectiveness and timing of one shot transarterial infusion and/or transcatheter arterial embolization therapy for recurrence of postoperative hepatocellular carcinoma].
    Author: Katsumata T, Fukai S, Utsunomiya T.
    Journal: Gan To Kagaku Ryoho; 1991 Aug; 18(11):1903-7. PubMed ID: 1652228.
    Abstract:
    From January '81 to April '91, one shot transarterial infusion therapy and transcatheter arterial embolization therapy were performed in five patients with recurrences of hepatocellular carcinomas after surgery. The results revealed as follows: (1) Mean duration from surgery to initial arterial infusion and/or embolization therapy was 44.3 months, except one recurrence occurred in a short time. (2) The longest survival was 100 months, and mean survival was 64.8 months. One expired with multiple organ failure after arterial embolization therapy, but the others survived and could return to life in society. These results suggested that one shot transarterial infusion therapy and/or transcatheter arterial embolization therapy was effective long-term intermittent treatment for recurrence of postoperative hepatocellular carcinoma.
    [Abstract] [Full Text] [Related] [New Search]